Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.

Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.

Prof. David J. Kuter is Distinguished Physician at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. A former Chief of Hematology at MGH, he is a global leader in thrombopoietin biology and immune thrombocytopenia. A Rhodes Scholar, he has authored over 350 publications, delivered 700+ international lectures, and received numerous prestigious teaching and research awards in hematology.